ABSTRACT
INTRODUCTION
Acute kidney injury (AKI) is common in intensive care units (ICUs) and adversely affects patient morbidity and mortality. [1] Despite this fact, there is no consensus on definition of AKI; the condition includes broad clinical spectrum from Sepsis is one of the most common medical problems in ICUs and is the most important risk factor for developing AKI. Therefore, many studies have assessed development of AKI. Incidence of various degrees of renal injury in these studies was as follows: 19% in patients with mild sepsis, 23% in severe sepsis patients, and 51% in patients with septic shock (serious enough to require dialysis for 15% to 20% of the patients with sepsis). [6, 7] Development of AKI and risk factors for AKI can vary in different clinical situations, such as head injury or subarachnoid hemorrhage, due to differences in treatment approach. Limited data are available regarding development of AKI in ICU patients with aneurysmal subarachnoid hemorrhage (aSAH). Search revealed only 1 study on this subject, which identified development of AKI in 0.8% to 7% of aSAH patients. However, evaluation criteria for diagnosing AKI were different at each center in this multicenter study. [8] There are also few studies on non-neurological complications after traumatic brain injury; incidence of AKI was reported to be 23%. [9] Although many studies have examined development of AKI in all ICU patients, very few investigations have targeted specific ICU patient groups, such as those with subarachnoid hemorrhage, head injury, severe sepsis, and septic shock. Therefore, present study was conducted to compare 3 different patient groups (head injury, aSAH, and severe sepsis/septic shock) at 3 different ICUs for risk factors and development of AKI.
MATERIALS AND METHODS
This study was performed in neurosurgery ICU, emergency surgery and traumatology ICU, and adult general ICU after approval was obtained from the Istanbul Medical Faculty ethics committee. Patients were enrolled in the study after providing written, informed consent. This study began on January 1, 2010. First 100 patients who had the following diagnoses from each ICU were evaluated: aSAH in neurosurgery ICU, head injury in emergency surgery and traumatology ICU, and sepsis in adult general ICU. Selection criteria for patients were as follows: ICU stay of more than 48 hours, age over 18 years, absence of chronic renal failure, and lack of pre-existing renal transplantation. Severe sepsis and septic shock were diagnosed based on the American College of Chest Physicians/ Society of Critical Care Medicine consensus criteria. [10] Patients were monitored daily for development of renal failure based on AKIN classification criteria. [2] Follow-up period was limited to 30 days.
Groups were as follows: aSAH patients in neurosurgery ICU (aSAH group), severe sepsis and septic shock patients in adult general ICU (sepsis group), and head injury patients in emergency surgery and traumatology ICU (head injury group). Age, gender, and additional diseases that could contribute to development of acute or chronic renal failure were recorded for each patient enrolled in the study. All patients were also evaluated on admission to ICU with APACHE II score using worst values of first day to evaluate disease severity. Common parameters of presence of infection, requirement for mechanical ventilation support, use of antibiotic therapy, use of vasopressor support, use of steroids or insulin, or presence of hyponatremia or hypernatremia were recorded. Degree of renal failure was determined based on AKIN classification. [2] Patients were evaluated every day, and total urine output (in 24 hours) and/or daily Cr value was recorded. Data of each patient, including use of renal replacement therapy, length of ICU stay, and survival information, were recorded at end of ICU stay. Volume adjusted creatinine (VACr) level for all patient groups was calculated using the following formula described by Lui et al.: VACr = SCr x (1 + cumulative net fluid balance / total body water), in which SCr is measured serum creatinine and total body water is 0.6 x patient weight on ICU admission. SCr, VACr level, and urine output were used to determine AKI level in all patients. [11] Hydration and hypertension (2H) therapy were used to treat vasospasm in aSAH group, in contrast to other groups. Criteria for initiating 2H therapy included at least 2 minor signs of vasospasm (e.g., headache, agitation, rising white blood cell count without infection, development of new motor loss, decrease of more than 2 points on Glasgow Coma Scale [GCS]). For 2H therapy, at least 3500 mL/day intravenous fluid was used for hydration, and norepinephrine was used to induce hypertension (systolic blood pressure >160 mmHg). Clinical vasospasm was diagnosed with existence of 3 symptoms, such as headache, development of new neurological deficit, or decrease of more than 2 points on GCS.
All the data were evaluated using SPSS 16.0 statistical program for Windows (IBM Corp., Armonk, NY, USA). Data were expressed as mean value±standard deviation, and categorical variables were expressed as percentage of number of cases. P value <0.05 was considered significant. Chi-square test, Mann-Whitney U test and multivariate logistic regression analysis (to determine risk factors for AKI development and mortality) were used to determine clinically and statistically significant variables that were predeterminants of acute renal failure and mortality.
RESULTS
Total of 300 patients were evaluated in this study. Demographic data of the groups and morbidity and mortality rates are displayed in Table 1 . Sepsis group exhibited highest mortality; aSAH group mortality rate was lower than that of head injury group (Table 1 ).
Development of AKI
VACr level was calculated for all groups, but result only differed from SCr level in aSAH group. Although there was no AKI in aSAH group according to SCr level, there were 5 (5%) patients with AKI based on VACr level. AKI developed in 76 patients (76%) in sepsis group, and also developed in 20 patients (20%) in head injury group, based on AKIN classification. AKI incidence in aSAH, head injury, and sepsis groups is provided in Table 2 ; difference between groups was statistically significant (p<0.01). Cr value at admission and discharge from ICU were compared between groups; Cr value was similar for all groups at admission (p=0.68). However, upon last measurement before discharge, average Cr value was significantly higher in sepsis group than in the other 2 groups according to both SCr and VACr levels (p<0.001). Furthermore, average Cr value on discharge was significantly higher in head injury group than in aSAH group (p=0.006). Blood urea nitrogen (BUN) value at admission to ICU was statistically higher in sepsis group than in the other groups (p<0.001). Mean BUN value was lowest in aSAH group at discharge from ICU, and it was highest in sepsis group (p<0.001) ( Table 3) . Cr value decreased from admission to discharge only in aSAH group; in this group, 64% of the patients received 2H therapy for vasospasm. Moreover, in aSAH group, 38% of patients developed sodium imbalance, 32% of the patients exhibited cerebral salt-wasting syndrome or syndrome of inappropriate antidiuretic hormone secretion-induced hyponatremia (<130 mEq/L), and 6% of the patients had hypernatremia with diabetes insipidus (>155 mEq/L).
Evaluation of risk factors associated with development of AKI Illness Severity Score: Sepsis group average APACHE II score was significantly higher than that of the other 2 groups (p<0.001), and head injury group average APACHE II score was higher than that of aSAH group (p<0.001) ( Table 4) .
Age: Age of sepsis and aSAH groups was significantly higher than age of head injury group (p<0.0001), but there was no significant difference between age of sepsis and aSAH groups (p=0.41) ( Table 1) .
ICU length of stay:
Length of stay in ICU was significantly higher in sepsis group than in head injury group (p<0.001); there was no significant difference between sepsis and aSAH groups (Table 4) .
Vasopressor use: Use of vasopressor was significantly higher in sepsis group than other groups (p<0.001), and it was similar between head injury and aSAH groups (p=0.503) ( Table 4) .
ICU infections:
As expected, number of infections in sepsis group was significantly higher than in head injury and aSAH groups (p<0.001); there was no significant difference in in- cidence of infection between head injury and aSAH groups (p=0.387) ( Table 4 ).
Antibiotic use: Average duration of antibiotic use was significantly higher in sepsis group than in other groups (p<0.001), but was similar between aSAH and head injury group (p=0.738) ( Table 4 ).
Insulin use:
There was greater use of insulin in sepsis group; however, there was no statistically significant difference between groups (p=0.035) ( Table 4) .
Steroid use: Steroids were used to treat all the patients in aSAH group, and usage was statistically significant compared with other 2 groups (p<0.001). However, use of steroids was similar between sepsis and head injury groups (p=0.875) ( Table 4 ).
Mechanical ventilation:
Requirement for mechanical ventilation in sepsis and head injury groups was similar (p=0.454), and it was significantly higher in these groups compared with aSAH group (p=0.004) ( Table 4) . Vasopressor use was only significant risk factor for development of AKI in sepsis and head injury groups; however, high APACHE II score, as well as steroid and antibiotic use, were determined to be risk factors for AKI when all groups were analyzed collectively. We calculated VACr level according to fluid balance in aSAH group. Although there was no AKI in aSAH group according to SCr level, after fluid adjustment and corrected calculation of Cr, 5 patients received Stage 1 AKI diagnosis. Intense fluid management could influence SCr and Cr-based diagnosis of AKI. [11, 12] Cr level could be low due to fluid overload as result of dilution. [12] For this reason, we used VACr level in addition to SCr. But we did not observe any problem related to AKI, such as longer hospital stay or inhospital mortality, in this group of patients. Solenski et al. performed multicenter study of 457 aSAH patients in ICU in which they evaluated non-neurological problems, and they determined that AKI incidence in that group of patients was between 0.8% and 7%. [8] However, AKI was diagnosed only by rise in Cr and/or urea value. To our knowledge, the present study is the only one to utilize current AKI evaluation criteria for aSAH patients. Two main reasons may explain difference between our findings and Solenski's results on development of AKI. First, our patients exhibited normal renal function. Almost one-fifth of all ICU patients have different degrees of renal impairment, [5] but this status was not indicated in Solenski's study; thus, mild renal impairment in those patients on admission to ICU might explain rate of AKI in that study. Second, there could have been a type II error in our study due to small number of patients. Another research group that evaluated effect of AKI on survival of aSAH patients (using RIFLE classification) determined that AKI patients exhibited 3-fold increase in mortality rate compared with non-AKI patients; this risk factor for poor prognosis confirmed patient statistics in our study. [5] However, there are no data indicating that AKI either developed in ICU or was acquired on admission to this study. AKI patients with sepsis are older and have higher mortality rates and APACHE II scores compared with septic patients who do not develop AKI.
Evaluation of Mortality According To AKI
[13] Although our single-center study had limited number of patients, these findings confirmed our results. Several investigations have revealed that AKI develops in approximately 11% to 42.1% of all sepsis cases depending on severity of the illness. [14, 15] In a German multicenter study, AKI developed in approximately 41.4% of severe sepsis and septic shock cases. [16] In our study, AKI developed in 76% of patients in sepsis group. This rate is higher than that reported in other studies and might be explained by fact that 62% of the patients in sepsis group were in septic shock; however, this rate was not indicated in German study. Risk for development of AKI in sepsis group was increased by use of antibiotics and vasopressors. In another study, in which 415 severe sepsis and septic shock patients were examined for development of AKI, mortality rate was 39.5% in non-AKI patients but was 64.6% in AKI patients (p<0.001). However, in this study, only development of AKI was determined to be significant risk factor for mortality. [17] In our study, mortality rate for sepsis patients without AKI was 14.3% (2/14), but was 52.8% (19/36) for sepsis patients with AKI; this difference was significant (p=0.013). Li et al. reported that AKI developed in 23% of 136 traumatic brain injury patients (based on AKIN classification) and that average age of patient group who developed AKI was higher. They also found that mortality rate was greater in AKI group. [18] In another study, based on RIFLE classification system, incidence of AKI was 9.2%, and these patients were significantly older and had higher APACHE II scores compared with non-AKI patients. [19] Furthermore, mortality rate was 42.1% in the patients who developed AKI and 18.1% in non-AKI patients. [19] In our study, AKI developed in 20% of head injury patients, based on AKIN classification. Majority of the patients were male. Multivariate analysis revealed that vasopressor use (p=0.044) was the only risk factor for developing AKI. We found no factor related to mortality. Mortality rate in this group was 19% (8/42) for non-AKI patients and 37.5% for AKI patients, but difference was not statistically significant.
When all of the patients were assessed collectively, use of vasopressors (OR: 2.21, 95% CI: 0.45-4.01; p=0.012) and need for mechanical ventilation (OR: 1.53, 95% CI: 0.90-2.15; p=0.013) were determined to be risk factors for mortality. However, development of AKI alone had no effect on mortality, in contrast with sepsis group. We suppose that this significant difference is due to younger patient profile in head injury group, which had smaller comorbid disease ratio and lower mortality rate among AKI patients compared with sepsis group. Whereas similar age, ICU length of stay, comorbid diseases, and Cr and BUN values were observed on admis-sion in aSAH group compared with sepsis group, similar infection rate and similar use of antibiotics and vasopressors were observed in head injury group. Moreover, steroids were used by all of the patients in aSAH group. Although aSAH group had similar risk factors for developing AKI compared with the 2 other groups, Stage 1 AKI based on VACr value developed in only 5 patients. Most of the patients with even minor signs of vasospasm underwent 2H therapy in aSAH group; we believe that this therapy could protect renal function. In addition, we also believe that electrolyte imbalance that commonly occurs in this patient group (due to cerebral salt-wasting syndrome, inappropriate secretion of antidiuretic hormone or central diabetes insipidus) and causes polyuria could also protect against renal injury. Risk factors for development of AKI were higher age, higher disease-severity scores (APACHE II and SOFA), vasopressor therapy, sepsis, pre-existing renal insufficiency, malignancy, and pulmonary disease.1 When all of the patients in our study were evaluated using multivariate regression analysis, APACHE II score (OR: 1.21, 95% CI: 1.09-1.31; p<0.001) and use of steroids (OR: 7.32, 95% CI: 5.04-9.58; p=0.003) or antibiotics (OR: 1.21, 95% CI: 1.00-1.40; p=0.043) were determined to be risk factors for development of AKI.
In conclusion, AKI developed in only 5% of aSAH patients, but occurred in 70% of the patients in sepsis group, and 20% of the patients in head injury group. Conditions and risk factors were similar in all groups, but 2H therapy was applied to 64% of aSAH patients. In addition, centrally originating electrolyte imbalances that cause polyuria may explain low incidence of AKI among aSAH patients. Results of our investigation might not accurately reflect general population as it was single-center study that included limited number of patients who were also renally intact. Therefore, multicenter studies with larger and more homogeneous patient populations are necessary to obtain more representative results.
